This report covers the period July 1, 2020 through September 30, 2021. View and download the 2020-2021 Annual Report.
Innovative Patient Care
- Vitreoretinal Lymphoma: from Symptoms to Diagnosis to Treatment
- Kellogg Offers Multiple Options for Limbal Stem Cell Deficiency
- Collaborating to Deliver Specialized Care
- In it Together
- Finding a Personalized Solution for Dry Eye
- Prioritizing Communication for Patient Safety
- Kellogg Leads International Team Linking Family’s Symptoms to Rare, Inherited Syndrome
Training the Leaders and Best
- Michigan Medicine to Establish Neural Engineering Training Program
- Kellogg Addresses Technician Shortage with Ongoing Training Program
- U-M Learners Produce Online Newsletter
- Genetically-Modified Occludin Shown to Protect Against Diabetes-Related Vision Loss
- Guarding Photoreceptor Metabolism to Prevent Vision Loss in Inherited Retinal Diseases
- Kellogg’s Latest Heed Fellows
Advancing Eye Care for Patients and Populations
International Partnerships
Philanthropy
Faculty Honors and Awards
Advances from the Bench to the Bedside
- Finding New Pathways for the Treatment of Choroideremia
- Mapping the Genetic Landscape of Nanophthalmos
- Lipid Droplets May Protect Against AMD
- A New Regulator of Retinal Angiogenesis Discovered
- Innovation in Action
- State-of-the-Science Microscope Gives Kellogg Researchers New Edge
- Toward a Therapeutic Target for Proliferative Vitreoretinopathy
- Next-Generation Tools to Treat Abnormal New Ocular Blood Vessels
Kellogg Updates